P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

• T. Facon,
• T. Plesner,
• S. Usmani,
• S. Kumar,
• N. Bahlis,
• C. Hulin,
• R. Orlowski,
• H. Nahi,
• P. Mollee,
• K. Ramasamy,
• M. Roussel,
• A. Jaccard,
• M. Delforge,
• L. Karlin,
• B. Arnulf,
• A. Chari,
• H. Pei,
• N. Gupta,
• S. Kaila,
• K. Matt,
• K. Gries,
• R. Carson,
• F. Borgsten,
• K. Weisel,
• A. Perrot

Affiliations

T. Facon

1 University of Lille, Lille, France

T. Plesner

2 Vejle Hospital and University of Southern Denmark, Vejle, Denmark

S. Usmani

3 Memorial Sloan Kettering Cancer Center, New York, NY

S. Kumar

4 Mayo Clinic, Rochester, NY

N. Bahlis

5 University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB

C. Hulin

6 Hôspital Haut Leveque, University Hospital, Pessac, France

R. Orlowski

7 The University of Texas MD Anderson Cancer Center, Houston, TX

H. Nahi

8 Karolinska Institute, Karolinska University Hospital at Huddinge, Stockholm, Sweden

P. Mollee

9 Princess Alexandra Hospital, Woolloongabba, Australia

K. Ramasamy

10 Oxford University Hospitals, NHS Foundation Trust, Oxford, UK

M. Roussel

11 Service d’hématologie clinique et de thérapie cellulaire, CHU de Limoges, Limoges, France

A. Jaccard

11 Service d’hématologie clinique et de thérapie cellulaire, CHU de Limoges, Limoges, France

M. Delforge

12 University Hospital Leuven, Leuven, Belgium

L. Karlin

13 Lyon University Hospital, Hematology Centre Hospitalier Lyon-Sud, Lyon, France

B. Arnulf

14 Immuno-Hématologie, Hospital Saint Louis, Paris, France

A. Chari

15 Mount Sinai School of Medicine, New York, NY

H. Pei

16 Janssen Research & Development, LLC, Titusville, FL

N. Gupta

17 Janssen Scientific Affairs, LLC, Horsham, United Kingdom

S. Kaila

17 Janssen Scientific Affairs, LLC, Horsham, United Kingdom

K. Matt

17 Janssen Scientific Affairs, LLC, Horsham, United Kingdom

K. Gries

18 Janssen Research & Development, Raritan, NJ

R. Carson

18 Janssen Research & Development, Raritan, NJ

F. Borgsten

18 Janssen Research & Development, Raritan, NJ

K. Weisel

19 University Medical Center Hamburg-Eppendorf, Hamburg, Germany

A. Perrot

20 CHU de Toulouse, IUCT-O, Université de Toulouse, Toulouse, France